160 related articles for article (PubMed ID: 35234079)
1. Hairy Cell Leukemia-Japanese Variant: Report of a Patient and Literature Review.
Ito M; Harada T; Lang L; Saga T; Kanagawa M; Matsuda R; Yashiro S; Kano S; Sasaki Y; Nakamine H
Int J Surg Pathol; 2022 Oct; 30(7):828-838. PubMed ID: 35234079
[TBL] [Abstract][Full Text] [Related]
2. CD27-positive hairy cell leukemia-Japanese variant.
Tabata R; Tabata C; Iwama H; Yasumizu R; Kojima M
Virchows Arch; 2016 Mar; 468(3):375-9. PubMed ID: 26868143
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.
Tóth-Lipták J; Piukovics K; Borbényi Z; Demeter J; Bagdi E; Krenács L
Pathol Oncol Res; 2015 Jan; 21(1):203-11. PubMed ID: 24903677
[TBL] [Abstract][Full Text] [Related]
4. A Review on Splenic Diffuse Red Pulp Small B-Cell Lymphoma.
Yilmaz E; Chhina A; Nava VE; Aggarwal A
Curr Oncol; 2021 Dec; 28(6):5148-5154. PubMed ID: 34940070
[TBL] [Abstract][Full Text] [Related]
5. [Splenic diffuse red pulp small B-cell lymphoma diagnosed by splenectomy initially mimicking hairy cell leukemia-Japanese variant].
Yamada Y; Miura M; Tagari M; Oshimi K; Shiragata T; Suga W; Takahashi T; Shimizu K; Ohshima K; Kajiwara K
Rinsho Ketsueki; 2018; 59(3):281-286. PubMed ID: 29618685
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow and splenic histology in hairy cell leukaemia.
Wotherspoon A; Attygalle A; Mendes LS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
[TBL] [Abstract][Full Text] [Related]
7. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
Maitre E; Cornet E; Salaün V; Kerneves P; Chèze S; Repesse Y; Damaj G; Troussard X
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205796
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma.
Suzuki T; Miyoshi H; Shimono J; Kawamoto K; Arakawa F; Furuta T; Yamada K; Yanagida E; Takeuchi M; Seto M; Sone H; Takizawa J; Ohshima K
Pathol Int; 2020 May; 70(5):280-286. PubMed ID: 32052529
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
[TBL] [Abstract][Full Text] [Related]
11. Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment.
Troussard X; Maitre E
J Cell Mol Med; 2024 Feb; 28(3):e18060. PubMed ID: 38095234
[TBL] [Abstract][Full Text] [Related]
12. [Case with hairy cell leukemia-Japanese variant following radiotherapy for orbital adnexal MALT lymphoma].
Nakamura Y; Kayano H; Kakegawa E; Uchida Y; Shimada T; Wakimoto N; Ito Y; Bessho M
Rinsho Ketsueki; 2010 Nov; 51(11):1674-9. PubMed ID: 21157131
[TBL] [Abstract][Full Text] [Related]
13. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
[TBL] [Abstract][Full Text] [Related]
14. Splenic B-cell lymphoma/leukemia with prominent nucleoli: A three-case series of the newly named old entity and review of literature.
Rai V; Saha A; Gondha S; Manimaran P; Sawhney J
J Cancer Res Ther; 2024 Jan; 20(1):315-320. PubMed ID: 38554340
[TBL] [Abstract][Full Text] [Related]
15. Deciphering Genetic Alterations of Hairy Cell Leukemia and Hairy Cell Leukemia-like Disorders in 98 Patients.
Maitre E; Tomowiak C; Lebecque B; Bijou F; Benabed K; Naguib D; Kerneves P; Cornet E; Viailly PJ; Arsham J; Sola B; Jardin F; Troussard X
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454811
[TBL] [Abstract][Full Text] [Related]
16. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Cornet E
Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
[TBL] [Abstract][Full Text] [Related]
17. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ
Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460
[TBL] [Abstract][Full Text] [Related]
19. [Hairy cell leukemia].
Maitre E; Wiber M; Cornet E; Troussard X
Presse Med; 2019; 48(7-8 Pt 1):842-849. PubMed ID: 31447330
[TBL] [Abstract][Full Text] [Related]
20. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Maître E; Cornet E
Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
